Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your trusted source for real-time updates and thorough ...

Additionally, Lenacapavir is currently under investigation for the prevention of HIV (PrEP) which is yet to be approved ...

Dr Reddy's Laboratories and Hetero, along with other generic drug makers, enter into voluntary licensing agreements with ...

Dr Reddy's Laboratories and Hetero sign non-exclusive, royalty-free agreements with Gilead Sciences to manufacture ...

Stay updated with the Dr. Reddy's Laboratories Stock Liveblog, your one-stop destination for real-time information and ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 inched up 0.74% to 6,743.20 Indian rupees Thursday, on what proved to be an ...

Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...

Lenacapavir is a US Food and Drug Administration (FDA) approved medication indicated for the treatment of HIV type 1 (HIV-1) ...

Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global ...

Dr Reddy’s Laboratories SA, Switzerland, an arm of Dr Reddy’s Laboratories, has completed the previously-announced ...

‘I live relatively frugally.’ I don’t have a huge income, and my IRA was ‘greatly diminished’ from a divorce 10 years ago.

Dr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP ...